Skip to main content

Table 3 Dose of ESA according to Hb level

From: Usefulness of mid-week hemoglobin measurement for anemia management in patients undergoing hemodialysis: a retrospective cohort study

 

Hb of < 10 g/dL

Hb of 10–11 g/dL

Hb of ≥11 g/dL

P-value

Early-week days

 Number of patients

8

64

20

 

 Hb (g/dL)

9.71 (9.23–9.97)

10.63 (10.03–10.99)

11.45 (11.01–12.24)

 

 ESA (μg/month)

311.67 (188.33–376.67)

179.17 (89.17–317.50)

93.34 (0–255.83)

< 0.001

Mid-week days

 Number of patients

2

65

25

 

 Hb (g/dL)

9.88 (9.81–9.94)

10.61 (10.03–10.97)

11.22 (11.0–12.87)

 

 ESA (μg/month)

292.5 (260–325)

183.33 (69.17–492.50)

95 (13.33–233.33)

< 0.001

P-value b

p = 0.125 a (p = 0.100 b)

 
  1. Values are given as number or median (range)
  2. a Comparing the number of patients for early-week days and mid-week days. b Comparing the number of patients with Hb levels of > 10.0 g/dL
  3. Hb, hemoglobin; ESA, erythropoiesis-stimulating agent